Metabolic and Muscular Adaptations During Inactivity in 3 Days of Bed-rest
Determination of the Time-course of Development of Insulin Resistance, and Associated Molecular and Muscular Adaptations, During Inactivity in 3 Days of Bed-rest
2 other identifiers
interventional
10
1 country
1
Brief Summary
Space flight is associated with detrimental changes to the human body, including bone and muscle loss, fluid changes and deconditioning of muscles in the heart and blood vessels. Bed rest experiments, on Earth, are used to study these changes in healthy volunteers, as the disuse of muscles, and impact on the body, mimic the changes seen in the low-gravity environment of Space. Moreover, these changes are similar to those reported in people who remain in bed for long periods of time, such as is seen in intensive care or stroke patients, and bed rest studies also allow the physiological and biochemical impacts of this confinement to be investigated. For example, we know from previous research that muscle inactivity can lead to the development of resistance to the action of the hormone 'insulin', which is a longer term risk factor for the development of type 2 diabetes. Previous studies suggest that this inactivity-induced insulin resistance occurs within the first 48 hours of immobilization. However, it is not clear whether the biochemical and physiological processes underlying these short-term responses to inactivity are the same as those seen in the longer term. The current study aims to investigate the biochemical and physiological changes seen after 3 days of bed rest and to compare to those measured in a previous 57 days bed rest study carried out at Institut Médecine Physiologie Spatiale (MEDES; Toulouse, France). A 3-day period of reconditioning will subsequently be used to determine if these changes can be readily reversed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2018
CompletedFirst Submitted
Initial submission to the registry
March 30, 2018
CompletedFirst Posted
Study publicly available on registry
April 11, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedJanuary 3, 2025
January 1, 2025
7 months
March 30, 2018
January 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Insulin stimulated whole body glucose uptake
Determined during a hyperinsulinemic, euglycemic clamp
after 3 days of bed rest, compared to pre-bed rest
Secondary Outcomes (18)
Change in Insulin stimulated whole body glucose uptake
after 3 days of reconditioning, compared to post-bed rest
Change in Insulin stimulated leg glucose uptake
after 3 days of bed rest, compared to pre-bed rest
Change in Insulin stimulated leg glucose uptake
after 3 days of reconditioning, compared to post- bedrest
Change in Whole body muscle mass
after 3 days of bed rest, compared to pre-bed rest
Change in Whole body muscle mass
after 3 days of reconditioning, compared to post- bed rest
- +13 more secondary outcomes
Study Arms (2)
Bed rest
EXPERIMENTALThree days of bed rest at -6 degrees of head-down tilt
Reconditioning
EXPERIMENTALThree days of one-legged knee extension contractions to recondition one leg
Interventions
Eligibility Criteria
You may qualify if:
- Physically and mentally healthy participants
- Body mass index 20 - 26 kg/m2
- Height 158 - 190 cm (62 - 75 inches),
- Participants that are able to consent to participation in the entire study
- Signed informed consent
You may not qualify if:
- regular use of prescribed or 'over-the counter' medication
- Bone mineral density (measured by Dual-Energy X-ray Absorptiometry) more than 1.5 standard deviation less than t-score
- Family history of thrombosis or positive response in thrombosis blood screening: Antithrombin III, High sensitive C-Reactive Protein, protein kinase B, F-V-Leiden, Prothrombin mutation, Lupus-prothrombin time, Factor II
- Any current medical condition
- A medical history of thyroid dysfunction, renal function disorder (including renal stones), diabetes, cardiac arrhythmias and cardiovascular disorders, migraines, allergies, hypertension, hypocalcaemia, uric acidaemia, lipidemia or hyperhomocysteinemia, hiatus hernia, bowel surgery or gastro-oesophageal reflux
- History of a mental health disorder
- Smoker within six months prior to the start of the study
- Dependence on drugs, medicine or alcohol
- History of orthostatic intolerance, vestibular disorders or claustrophobia
- Special food diet, vegetarian or vegan, history of intolerance to lactose or food allergy,
- Osteosynthesis material, presence of metallic implants, history of knee problems or joint surgery/broken leg,
- Orthopaedic or musculoskeletal disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
David Greenfield Human Physiology Laboratories
Nottingham, Notts, NG72UH, United Kingdom
Related Publications (5)
Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies. J Appl Physiol (1985). 2011 Oct;111(4):1201-10. doi: 10.1152/japplphysiol.00698.2011. Epub 2011 Aug 11.
PMID: 21836047BACKGROUNDLee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT; Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012 Jul 21;380(9838):219-29. doi: 10.1016/S0140-6736(12)61031-9.
PMID: 22818936BACKGROUNDDeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979 Sep;237(3):E214-23. doi: 10.1152/ajpendo.1979.237.3.E214.
PMID: 382871BACKGROUNDBrook MS, Wilkinson DJ, Mitchell WK, Lund JN, Phillips BE, Szewczyk NJ, Greenhaff PL, Smith K, Atherton PJ. Synchronous deficits in cumulative muscle protein synthesis and ribosomal biogenesis underlie age-related anabolic resistance to exercise in humans. J Physiol. 2016 Dec 15;594(24):7399-7417. doi: 10.1113/JP272857. Epub 2016 Nov 7.
PMID: 27654940BACKGROUNDShur NF, Simpson EJ, Crossland H, Chivaka PK, Constantin D, Cordon SM, Constantin-Teodosiu D, Stephens FB, Lobo DN, Szewczyk N, Narici M, Prats C, Macdonald IA, Greenhaff PL. Human adaptation to immobilization: Novel insights of impacts on glucose disposal and fuel utilization. J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2999-3013. doi: 10.1002/jcsm.13075. Epub 2022 Sep 4.
PMID: 36058634RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul L Greenhaff, PhD
University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research Fellow
Study Record Dates
First Submitted
March 30, 2018
First Posted
April 11, 2018
Study Start
January 8, 2018
Primary Completion
July 31, 2018
Study Completion
December 31, 2019
Last Updated
January 3, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share